
Loading summary
A
This is Scott Becker with a special episode of the Becker's Healthcare and Becker Private Equity podcast. Today's discussion is health insurers take it on the chin as a deal comes together in Washington, D.C. so here's the issue. Three of the major health insurance companies that are really involved in Medicare Advantage plans and Medicaid managed care plans, meaning today Oscar Health, Centene and Humana are all down significantly on the news that some of the Affordable Care act subsidies may not continue in the same way under the government shutdown deal that seems close to being reached. And just to give you a flavor for this, Oscar health is down 14%. Humana and Centene are down 5 to 7%. We'll see how that lasts and how it holds up. Now in terms of the other major insurers, they are not as dependent at the moment as they moved out of some of the Medicare Advantage markets. They're not as dependent on some of these subsidies as they once were. So they're not having as big of movement today. UnitedHealthcare year to date is down 36%. CVS Health for other reasons outside of Aetna is up 70/plus percent this year. Cigna, the third of the four insurance companies are top 20 by revenues in America, is down about 7% year to date. And finally Elevance Health, which is the former Anthem Blue Cross I think is down about 17% year to date. So again, a couple of the key insurers that really deal with Medicaid managed care plans and Medicare Advantage, Oscar Health, Centene, Ximena taking it on the chin today, the other four insurers, we've just gone through the year to date results and again we hope you find this informative. Feel free at any time to reach Scott becker at Becker's Healthcare, 773-766-5322. Also a separate company. Founder of Becker Business, Becker Private Equity More just so I keep on learning about business, not a true media company. Thank you for listening to the Becker's Healthcare podcast and the Becker Private Equity Podcast.
Title: Health Insurers Take it on the Chin as a Deal Comes Together in D.C.
Host: Scott Becker
Date: November 11, 2025
Theme:
Scott Becker provides an incisive real-time analysis of the immediate impacts felt by major U.S. health insurers as news emerges of a government shutdown deal in Washington, D.C. Central to this episode is the uncertainty surrounding the future of Affordable Care Act (ACA) subsidies and how this volatility ripples through the insurance market, with a sharp focus on Medicare Advantage and Medicaid managed care players.
Major Insurers Impacted:
Scott’s Analysis:
“Oscar Health is down 14%. Humana and Centene are down 5 to 7%. We’ll see how that lasts and how it holds up.” (00:38)
The market’s reaction is closely tied to the possibility that ACA subsidies may "not continue in the same way" as part of the near-final shutdown resolution.
Differing Levels of Exposure:
Scott’s Context:
“Now in terms of the other major insurers, they are not as dependent at the moment as they moved out of some of the Medicare Advantage markets. … So they’re not having as big of movement today.” (01:08)
Interpretation: The episode highlights the risk profiles in a sector that’s highly driven by government policy. Strategic shifts in business lines (as with UnitedHealthcare and others distancing from Medicare Advantage) provide relative insulation on days of major policy uncertainty.
Volatility Remains:
Scott reminds listeners to watch for the durability of these market moves, noting, “We’ll see how that lasts and how it holds up.” (00:48)
Transparency and Contact:
Scott invites feedback and questions, reinforcing his accessibility.
“Feel free at any time to reach Scott Becker at Becker’s Healthcare, 773-766-5322.” (02:28)
On Insurer Declines:
“A couple of the key insurers that really deal with Medicaid managed care plans and Medicare Advantage, Oscar Health, Centene, Ximena, taking it on the chin today.” (01:42)
On Broader Market Context:
“The other four insurers, we’ve just gone through the year to date results and again we hope you find this informative.” (01:48)
Scott’s delivery is brisk, analytical, and plugged-in to market realities—a style that both informs and cautions listeners about the sector’s sensitivity to Washington, D.C. proceedings. This episode offers a clear snapshot of financial market reactions in the context of real-time health policy news, making it invaluable for healthcare professionals and investors alike.